Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer - PubMed (original) (raw)
. 2006 May 1;106(9):1865-74.
doi: 10.1002/cncr.21822.
Affiliations
- PMID: 16568450
- DOI: 10.1002/cncr.21822
Free article
Why do men choose one treatment over another?: a review of patient decision making for localized prostate cancer
Steven B Zeliadt et al. Cancer. 2006.
Free article
Abstract
Treatment choices for localized prostate cancer appear to vary widely, although it is unclear whether this variation is a result of patient values or other factors. The authors conducted a systematic review of the literature, identifying 70 articles that focused on prostate cancer decision making. Studies suggest that men consider several issues when making treatment decisions. The authors found conflicting evidence regarding the importance that men place on cancer eradication, with considerable variation in how patients interpret evidence regarding treatment efficacy. The number of physicians that men see and the importance of the physician recommendation were found to vary considerably. Although men stated that side effects are important, few patients reported that side effect factors ultimately influenced their treatment choice. To the authors' knowledge, there is little research regarding how patients' personal values shape and influence their decision, or the role of race/ethnicity or socioeconomic status in preferences for treatment. The authors conclude that variations in treatment decisions may be more indicative of differences in the information patients receive rather than truly reflective of underlying patient preferences. Considerable progress is needed in helping patients fully understand how to balance the complex issues surrounding prostate cancer treatment decision making.
Similar articles
- Men's perspectives on selecting their prostate cancer treatment.
Xu J, Dailey RK, Eggly S, Neale AV, Schwartz KL. Xu J, et al. J Natl Med Assoc. 2011 Jun;103(6):468-78. doi: 10.1016/s0027-9684(15)30359-x. J Natl Med Assoc. 2011. PMID: 21830629 Free PMC article. - Current decision-making in prostate cancer therapy.
Cox J, Amling CL. Cox J, et al. Curr Opin Urol. 2008 May;18(3):275-8. doi: 10.1097/MOU.0b013e3282fba5f2. Curr Opin Urol. 2008. PMID: 18382237 Review. - What Is a "Good" Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer.
Orom H, Biddle C, Underwood W 3rd, Nelson CJ, Homish DL. Orom H, et al. Med Decis Making. 2016 Aug;36(6):714-25. doi: 10.1177/0272989X16635633. Epub 2016 Mar 8. Med Decis Making. 2016. PMID: 26957566 Free PMC article. - Health literacy and shared decision making for prostate cancer patients with low socioeconomic status.
Kim SP, Knight SJ, Tomori C, Colella KM, Schoor RA, Shih L, Kuzel TM, Nadler RB, Bennett CL. Kim SP, et al. Cancer Invest. 2001;19(7):684-91. doi: 10.1081/cnv-100106143. Cancer Invest. 2001. PMID: 11577809 - Patient decision aids for prostate cancer treatment: a systematic review of the literature.
Lin GA, Aaronson DS, Knight SJ, Carroll PR, Dudley RA. Lin GA, et al. CA Cancer J Clin. 2009 Nov-Dec;59(6):379-90. doi: 10.3322/caac.20039. Epub 2009 Oct 19. CA Cancer J Clin. 2009. PMID: 19841280 Review.
Cited by
- Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.
Taylor KL, Luta G, Miller AB, Church TR, Kelly SP, Muenz LR, Davis KM, Dawson DL, Edmond S, Reding D, Mabie JE, Riley TL. Taylor KL, et al. J Clin Oncol. 2012 Aug 1;30(22):2768-75. doi: 10.1200/JCO.2011.41.2767. Epub 2012 Jun 25. J Clin Oncol. 2012. PMID: 22734029 Free PMC article. - Improving the communication of benefits and harms of treatment strategies: decision AIDS for localized prostate cancer treatment decisions.
Hoffman RM. Hoffman RM. J Natl Cancer Inst Monogr. 2012 Dec;2012(45):197-201. doi: 10.1093/jncimonographs/lgs023. J Natl Cancer Inst Monogr. 2012. PMID: 23271773 Free PMC article. - A national survey of radiation oncologists and urologists on prediction tools and nomograms for localized prostate cancer.
Gershman B, Maroni P, Tilburt JC, Volk RJ, Konety B, Bennett CL, Kutikov A, Smaldone MC, Chen V, Kim SP. Gershman B, et al. World J Urol. 2019 Oct;37(10):2099-2108. doi: 10.1007/s00345-019-02637-6. Epub 2019 Jan 22. World J Urol. 2019. PMID: 30671637 - Life-Threatening Disparities: The Treatment of Black and White Cancer Patients.
Penner LA, Eggly S, Griggs JJ, Underwood W 3rd, Orom H, Albrecht TL. Penner LA, et al. J Soc Issues. 2012 Jun 25;68(2):10.1111/j.1540-4560.2012.01751.x. doi: 10.1111/j.1540-4560.2012.01751.x. J Soc Issues. 2012. PMID: 24319297 Free PMC article. - Survival gains needed to offset persistent adverse treatment effects in localised prostate cancer.
King MT, Viney R, Smith DP, Hossain I, Street D, Savage E, Fowler S, Berry MP, Stockler M, Cozzi P, Stricker P, Ward J, Armstrong BK. King MT, et al. Br J Cancer. 2012 Feb 14;106(4):638-45. doi: 10.1038/bjc.2011.552. Epub 2012 Jan 24. Br J Cancer. 2012. PMID: 22274410 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical